v3.23.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jul. 31, 2023
Apr. 30, 2023
Jul. 31, 2022
Apr. 30, 2022
Jul. 31, 2023
Jul. 31, 2022
Jan. 31, 2023
Operating activities:              
Net loss $ (3,437) $ (412) $ (19,991) $ (25,839) $ (3,849) $ (45,830) $ (65,938)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:              
Depreciation and amortization expense         9,089 8,702  
Bad debt expense         602 491  
Stock-based compensation expense         22,577 34,168  
Amortization of operating lease right-of-use assets         4,611 4,547  
Other, net         184 975  
Changes in operating assets and liabilities:              
Accounts receivable         54,943 45,808  
Prepaid expenses and other current assets         (538) (4,716)  
Costs to obtain revenue contracts         6,554 7,583  
Other long term assets         726 956  
Accounts payable, accrued expenses and other current liabilities         (14,158) 242  
Unearned revenue         (55,324) (54,154)  
Operating lease liabilities         (5,848) (5,991)  
Other long term liabilities         141 (86)  
Net cash provided by (used in) operating activities         19,710 (7,305)  
Investing activities:              
Capital expenditures         (1,567) (3,875)  
Net cash used in investing activities         (1,567) (3,875)  
Financing activities:              
Proceeds from exercise of stock options         8,610 525  
Repurchase of common stock         (10,996) (58,722)  
Payments for taxes related to net share settlement of stock-based compensation awards         (7,750) 0  
Payments of deferred financing costs         (301) (283)  
Proceeds, net from employee stock purchase plan withholdings         2,176 1,912  
Net cash used in financing activities         (8,261) (56,568)  
Effect of exchange rate changes on cash and cash equivalents         431 (5,556)  
Net increase (decrease) in cash and cash equivalents         10,313 (73,304)  
Cash and cash equivalents at beginning of period   $ 190,214   $ 261,210 190,214 261,210 261,210
Cash and cash equivalents at end of period $ 200,527   $ 187,906   $ 200,527 $ 187,906 $ 190,214

Source

HTML PDF
ZIP